The IRDAI directive is expected to ensure that all parties involved in the surrogacy process are protected from any unforeseen medical complications that may arise during the pregnancy and post-partum period, insurance officials said.
Insurance regulator IRDAI has asked insurance companies to provide comprehensive coverage for intending parents and surrogate mothers undergoing surrogacy and fertility treatments.
“An insurance coverage of such amount as may be prescribed for a period of 12 months in favour of the oocyte donor by the commissioning couple or woman from an insurance company or an agent recognised by the IRDAI,” the regulator said.
According to the IRDAI, the intending woman or couple can purchase a general health insurance coverage in favour of surrogate mother for a period of 36 months from an insurance company.
Amit Goel, Director & Principal Officer, Raghnall Insurance, said, “as the insurance industry evolves to meet the changing needs of society, it is important for insurers to recognize the increasing demand for surrogacy and fertility treatments.
The recent circular from IRDAI is a positive step towards providing comprehensive coverage for intending parents and surrogate mothers.”
The IRDAI directive is expected to ensure that all parties involved in the surrogacy process are protected from any unforeseen medical complications that may arise during the pregnancy and post-partum period, insurance officials said.
“We believe that this move will help promote the accessibility of surrogacy as a viable option for couples seeking to start a family, while also ensuring that all stakeholders are adequately covered,” Goel said.


